Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study-Reference-Cited by-同舟云学术

Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study

Published:2024-05-14 Issue: Volume: Page:
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Bozorg Soran R.¹²³^ORCID,Söderling Jonas⁴,Mårild Karl⁵⁶,Garber John J.⁷,Uchida Amiko⁸^ORCID,Neovius Martin⁴^ORCID,Ludvigsson Jonas F.¹⁹¹⁰^ORCID,Everhov Åsa H.⁴¹¹^ORCID

Affiliation:

1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;

2. Division of Gastroenterology, Karolinska University Hospital, Stockholm, Sweden;

3. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;

4. Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Gothenburg, Sweden;

5. Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;

6. Department of Pediatric Gastroenterology, Queen Silvia Children's Hospital, Gothenburg, Sweden;

7. Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;

8. Division of Gastroenterology, Hepatology and Nutrition, University of Utah School of Medicine, Salt Lake City, Utah, USA;

9. Department of Pediatrics, Örebro University Hospital, Örebro, Sweden;

10. Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA;

11. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Abstract

INTRODUCTION: Despite its increasing prevalence, the economic impact of eosinophilic esophagitis (EoE) is understudied. METHODS: We estimated the societal economic burden of EoE by using real-world data from Swedish health registers. RESULTS: Patients with EoE had 45% higher societal cost ($6,290 vs $4,349) compared with the general population, primarily driven by increased healthcare costs ($2,414 vs $1,022), which accounted for 72% of the excess societal cost in EoE. DISCUSSION: EoE is associated with a considerable economic burden to society. With the prevalence of EoE still rising, the economic burden of EoE is expected to continue to grow.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference11 articles.

1. Increasing incidence of eosinophilic esophagitis in Sweden: A nationwide population study;Garber;Esophagus,2022

2. Global incidence and prevalence of eosinophilic esophagitis, 1976-2022: A systematic review and meta-analysis;Hahn;Clin Gastroenterol Hepatol,2023

4. Health-care utilization, costs, and the burden of disease related to eosinophilic esophagitis in the United States;Jensen;Am J Gastroenterol,2015

5. Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden);Ludvigsson;Clin Epidemiol,2019